Product Information
GNP ALLERGY RELIEF 5 MG TABLET is a generic product labeled by AmerisourceBergen, priced at $0.2183 per EA under NDC 46122053161. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jan 19, 2018.
Strength
5 mg/1
Manufacturer
AmerisourceBergenNDC
46122053161
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210375FDA Approved
1/19/2018
On Market Since
4/20/2018
Pharmacological Classes
Price Statistics
The NADAC for GNP ALLERGY RELIEF 5 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 13.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2183 per EA |
|---|---|
| All-time high | $0.2231 (Aug 12, 2026) |
| All-time low | $0.1573 (Aug 21, 2024) |
| 52-week high | $0.2231 |
| 52-week low | $0.1830 |
| Median price | $0.1855 |
| Average price | $0.1891 |
| Largest weekly change | +26.2% (Sep 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 77% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
levocetirizine dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP ALLERGY RELIEF 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GNP ALLERGY RELIEF 5 MG TABLET, manufactured by AmerisourceBergen, is $0.2183 per EA (NDC 46122053161), effective Sep 30, 2026.
How has the price of GNP ALLERGY RELIEF 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for GNP ALLERGY RELIEF 5 MG TABLET has risen 13.7%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for GNP ALLERGY RELIEF 5 MG TABLET?
Since Apr 17, 2024, the NADAC for GNP ALLERGY RELIEF 5 MG TABLET has ranged from a low of $0.1573 (Aug 21, 2024) to a high of $0.2231 (Aug 12, 2026), with a median of $0.1855 per EA.
Are there cheaper alternatives to GNP ALLERGY RELIEF 5 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVOCETIRIZINE 5 MG TABLET, is $0.0511 per EA — about 77% below GNP ALLERGY RELIEF 5 MG TABLET.
Who manufactures GNP ALLERGY RELIEF 5 MG TABLET?
GNP ALLERGY RELIEF 5 MG TABLET (NDC 46122053161) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.